Search results
Here's Why Merck (MRK) Stock Has Outperformed Industry YTD
Zacks· 6 days agoFree Report) boasts more than six blockbuster drugs in its portfolio, with PD-L1 inhibitor Keytruda approved for several types of cancer and alone accounting for more than 45% of the company ...
Novavax awaits FDA decision on whether its next COVID shot can be offered in US
Reuters via Yahoo News· 1 day agoNovavax will only be able to offer a COVID-19 vaccine in the United States this autumn if regulators...
Why Novavax (NVAX) Stock Price Appreciated 14% on Monday
Zacks via Yahoo Finance· 5 days agoNovavax (NVAX) surges after one of its top shareholders drops a proxy campaign against the company....
Could current COVID vaccines protect against future outbreaks? New study offers hope
Orange County Register· 3 days agoA group of researchers had the future in mind when they asked if current COVID-19 vaccines and...
Cleburne rebounds from four runs down to end RedHawks' win streak
The Fargo Forum· 24 hours agoCleburne rallied from four runs down to defeat Fargo-Moorhead 9-5 on Friday at La Moderna Field. The...
Dow Jones Dips As AI Stock Microsoft Shines; Nvidia Rallies On These Bullish Calls
Investor's Business Daily· 5 days agoTechnology was a top performer in the composite, rallying 3% after Morgan Stanley upgraded the stock...
3 Cathie Wood Stocks to Buy Now: May 2024
InvestorPlace· 4 days agoCathie Wood’s ARK Invest funds were unstoppable in 2020 as investors piled into disruptive innovation stocks during the low-rate lockdown environment. After peaking in early 2021, the ARK funds ...
The Zacks Analyst Blog Highlights Stocks recently featured in the blog include: Novo Nordisk, Eli...
Zacks via Yahoo Finance· 6 days agoAfter all, Moderna was not the behemoth it is today. Until 2020-end, the company lacked a marketed...
Biotech stocks are rising alongside bird flu fears
Semafor via Yahoo Finance· 2 days agoVaccine makers, including Moderna, BioNTech, and CureVac, all saw double-digit stock increases, as investors bet they could cash in on a public health...
Free COVID-19 vaccines could be a thing of the past. Experts weigh in.
USA TODAY via Yahoo News· 4 days agoVaccine manufacturers Novavax and Pfizer said via email they planned to assess their accessibility...